162 related articles for article (PubMed ID: 16782976)
1. Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients.
Suzuki T; Masaki G; Ogawa S
Br J Anaesth; 2006 Aug; 97(2):160-3. PubMed ID: 16782976
[TBL] [Abstract][Full Text] [Related]
2. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
[TBL] [Abstract][Full Text] [Related]
3. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children.
Bevan JC; Collins L; Fowler C; Kahwaji R; Rosen HD; Smith MF; de Scheepers LD; Stephenson CA; Bevan DR
Anesth Analg; 1999 Aug; 89(2):333-9. PubMed ID: 10439743
[TBL] [Abstract][Full Text] [Related]
4. Comparison of neostigmine induced reversal of vecuronium in normal weight, overweight and obese female patients.
Joshi SB; Upadhyaya KV; Manjuladevi M
Indian J Anaesth; 2015 Mar; 59(3):165-70. PubMed ID: 25838588
[TBL] [Abstract][Full Text] [Related]
5. Conditions to optimise the reversal action of neostigmine upon a vecuronium-induced neuromuscular block.
Baurain MJ; Dernovoi BS; D'Hollander AA; Hennart DA; Cantraine FR
Acta Anaesthesiol Scand; 1996 May; 40(5):574-8. PubMed ID: 8792887
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of atracurium-induced block in obese patients.
Kirkegaard-Nielsen H; Lindholm P; Petersen HS; Severinsen IK
Can J Anaesth; 1998 Jan; 45(1):39-41. PubMed ID: 9466025
[TBL] [Abstract][Full Text] [Related]
7. Epidurally administered mepivacaine delays recovery of train-of-four ratio from vecuronium-induced neuromuscular block.
Suzuki T; Mizutani H; Ishikawa K; Miyake E; Saeki S; Ogawa S
Br J Anaesth; 2007 Nov; 99(5):721-5. PubMed ID: 17855735
[TBL] [Abstract][Full Text] [Related]
8. [Effects of halothane and sevoflurane on reversal of neuromuscular blockade induced by vecuronium in man].
Izawa H; Takeda J; Fukushima K
Masui; 1997 Feb; 46(2):177-83. PubMed ID: 9071099
[TBL] [Abstract][Full Text] [Related]
9. Reversal of vecuronium with neostigmine in patients with diabetes mellitus.
Saitoh Y; Hattori H; Sanbe N; Nakajima H; Akatu M; Murakawa M
Anaesthesia; 2004 Aug; 59(8):750-4. PubMed ID: 15270964
[TBL] [Abstract][Full Text] [Related]
10. Reversal of vecuronium with neostigmine: a comparison between male and female patients.
Saitoh Y; Aoki K; Okazaki M; Hirama T; Isosu T; Murakawa M
Fukushima J Med Sci; 2009 Dec; 55(2):61-70. PubMed ID: 20608096
[TBL] [Abstract][Full Text] [Related]
11. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
[TBL] [Abstract][Full Text] [Related]
12. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Bülow K
J Clin Anesth; 1995 Dec; 7(8):635-9. PubMed ID: 8747561
[TBL] [Abstract][Full Text] [Related]
13. Neostigmine reversal of vecuronium neuromuscular block and the influence of renal failure.
Dhonneur G; Rebaine C; Slavov V; Ruggier R; De Chaubry V; Duvaldestin P
Anesth Analg; 1996 Jan; 82(1):134-8. PubMed ID: 8712389
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of vecuronium-induced neuromuscular block in patients pretreated with magnesium sulphate: dose-effect relationship of neostigmine.
Fuchs-Buder T; Ziegenfuss T; Lysakowski K; Tassonyi E
Br J Anaesth; 1999 Jan; 82(1):61-5. PubMed ID: 10325838
[TBL] [Abstract][Full Text] [Related]
15. Optimum time for neostigmine administration to antagonize vecuronium-induced neuromuscular blockade.
Kirkegaard-Nielsen H; Toft P; Severinsen IK; May O
Eur J Anaesthesiol; 1995 Nov; 12(6):585-9. PubMed ID: 8665881
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting neostigmine reversal of vecuronium block during sevoflurane anaesthesia.
Morita T; Kurosaki D; Tsukagoshi H; Shimada H; Sato H; Goto F
Anaesthesia; 1997 Jun; 52(6):538-43. PubMed ID: 9203879
[TBL] [Abstract][Full Text] [Related]
17. Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial.
Horrow JC; Li W; Blobner M; Lombard J; Speek M; DeAngelis M; Herring WJ
BMC Anesthesiol; 2021 Feb; 21(1):62. PubMed ID: 33639839
[TBL] [Abstract][Full Text] [Related]
18. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium?
Baurain MJ; Hoton F; D'Hollander AA; Cantraine FR
Br J Anaesth; 1996 Oct; 77(4):496-9. PubMed ID: 8942335
[TBL] [Abstract][Full Text] [Related]
19. Effect of epidural levobupivacaine on recovery from vecuronium-induced neuromuscular block in patients undergoing lower abdominal surgery.
Sahin SH; Colak A; Sezer A; Arar C; Sevdi S; Gunday I; Sut N
Anaesth Intensive Care; 2011 Jul; 39(4):607-10. PubMed ID: 21823377
[TBL] [Abstract][Full Text] [Related]
20. Observational study on patterns of neuromuscular blockade reversal.
Dubovoy T; Housey M; Devine S; Kheterpal S
BMC Anesthesiol; 2016 Oct; 16(1):103. PubMed ID: 27770778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]